We have generated transgenic mice harboring the deletion of exon 48 in the mouse alpha 1(II) procollagen gene (Col2a1). This was the first dominant-negative mutation identified in the human alpha 1(II) procollagen gene (COL2A1). Patients carrying a single allele with this mutation suffer of a severe skeletal disorder named Spondylo-Epiphyseal Dysplasia (SED) Congenita. Transgenic mice phenotype was neonatally lethal with severe respiratory failure, short bones and cleft palate. Transgene mRNA was expressed at high levels. Growth plate cartilage of transgenic mice presented morphological abnormalities and reduced number of collagen type II fibrils. Chondrocytes carrying the mutation showed altered expression of several differentiation markers, like fibroblast growth factor receptor 3 (Fgfr3), Indian hedgehog (Ihh), runx2, cyclin-dependent kinase inhibitor P21 CIP/WAF (Cdkn1a) and collagen type X (Col10a1), suggesting that a defective extracellular matrix (ECM) depleted of collagen fibrils affects chondrocytes differentiation and this defect participates to the reduced endochondral bone growth observed in chondrodysplasias caused by mutations in COL2A1.
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INTRODUCTION
Endochondral bone formation and growth is strictly dependent on chondrocyte differentiation (2) . Extracellular matrix (ECM) plays an important role in controlling cell differentiation (6, 25) . During endochondral bone formation the composition of ECM changes at different developmental stages (2) .
Modifications of ECM composition are associated with the transition from the transient cartilaginous template to the permanent bone scaffold (10) . The proliferation of chondrocytes and their capacity to control the expression of the proper ECM genes before terminal differentiation are critical in this process (2) .
Genetic defects in ECM components of cartilage are associated with short stature, abnormal bone shape and reduced bone growth (11) . The precise mechanisms involved in these diseases are poorly understood. To better understand how defective cartilage ECM can alter skeletal development, transgenic mice with several dominant-negative mutations in type II procollagen, the major collagen of the cartilage matrix, have been generated (27, 4, 22) . They have remarkably similar phenotypes. Their bones are short, curved and, when the mutations are viable, predisposed to osteoarthritis (8) . The study of these experimental models was not focused to recognize defective chondrocyte differentiation as a critical step in the genesis of the skeletal problem. However, several mouse mutants with defined defects in chondrocyte differentiation, as PTHrP (13) and Ihh (26) null mice, show very similar phenotype and skeletal abnormalities. This similarity raises the question whether the defective ECM can also modify the ability of chondrocytes to follow a correct maturation pattern to sustain bone growth.
To investigate how a defective extracellular environment could affect chondrocyte differentiation in vivo, in an entire transgenic organism, we have used a transgenic mouse strain over-expressing a dominant-negative collagen type II, lacking 36 amino acids at the carboxyl terminal end of the triple helical region. The mutation consisted in the deletion of exon 48, corresponding to the last triple helical coding exon of Col2a1, and was designed from the first reported human mutation identified in Spondylo-Epiphyseal Dysplasia Congenita (SED) (15) .
MATERIALS AND METHODS

Generation and Identification of transgenic mice
The entire mouse Col2a1 gene was cloned from a cosmid library (21) and engineered with the exon 48 mutation. The deletion was created joining the BspHI and NcoI restriction sites flanking exon 48 in a XbaI-BamHI genomic fragment containing the 3' end of Col2a1 ( figure 1A) . Therefore, the deletion also removed 85 bp in intron 47 and 99 bp in intron 48. Including the exon sequence, the deletion consisted of 292 bp. Using the XbaI-BamHI fragment with the deletion, the entire Col2a1 genomic locus was reconstituted in a 42 kb long cosmid clone, as described in figure 1A . The NotI-ClaI fragment with 5' end of the gene, from the promoter to exon 14, was also engineered with a silent mutation that abolishes the NcoI site in exon 7 and allows transgenic identification (figure 1B). The transgene DNA was released from the cosmid vector pWE15 by Not I digestion and separated in agarose gel. After purification by electroelution, it was microinjected into the pronuclei of one-cell B6D2F1 mouse embryos that were then implanted into CD1 pseudopregnant foster mothers (9) . Transgenic founder mice could be recognized by Nco I digestion of tail genomic DNA and Southern blot (figure 1B) (4).
Transgene copy number was estimated by the intensity of transgene specific band compared to those generated by the endogenous Col2a1 alleles. It was calculated as the half ratio of the intensities of transgene over endogenous bands.
Transgene RNA expression
The amount of transgene mRNA was measured by reverse transcriptase-PCR (RT-PCR) from whole limb RNA. The primers for the reaction were in exon 46 (O9: ACACCGAGGTTTCACTGGA) and in exon 49 (O10: GCAAAGGCTGACATGTCGA) and amplified a 280 bp long fragment. In transgenic figure 1C ) and the intensity of the bands measured. Transgene RNA was expressed as a percentage of wild type Col2a1 RNA. This ratio was constant in different transgenic mice after collection of aliquots of the same PCR reaction from cycle 10 to 20 (linear amplification).
Gross examination, histology and electron microscopy
The fetuses were removed by cesarean section from day 14. 
Growth plate morphometric analysis
The proximal epiphysis of the second metatarsal bone was chosen for quantitative analysis of cartilage.
The analysis was performed with a semiautomatic image analyzer (IAS2000, Delta System, Rome, Italy 
Statistical analysis
A statistical comparison between transgenic and wild type mice was performed for thickness of reserve, proliferative, pre-hypertrophic and hypertrophic cartilage, and BrdU and TUNEL labeling index. Data were reported as mean + standard deviation. Comparisons between groups were made by one-way ANOVA and post hoc comparison was carried out with Scheffe's test. A probability level of 5% was used to establish a significant difference.
RESULTS
Lethal short-limbed dwarfism in transgenic mice with a 36 amino acid deletion in collagen II
Three transgenic lines carrying the Del48 transgene were generated and exhibited the same phenotype, two of these were studied in great detail. Over 100 transgenic embryos, carrying several copies of transgene, were generated and analyzed. The two founders were mosaic and phenotypically normal, while the entire progeny carrying the same transgene copy number revealed the severe phenotype of a lethal chondrodysplasia ( figure 2A ). This phenotype was fully penetrant, with none of the transgenic mice surviving beyond birth because of acute neonatal respiratory distress. The respiratory failure was due to simultaneous defects in the volume of the thorax from reduced growth of the ribs and in the airway diameter from structural defects in tracheal cartilages. Newborn transgenic mice were unable to breathe, became cyanotic and died within minutes after birth with severe heart and liver congestion. Gross and histopathological examination of lungs revealed no sign of inflation.
A short snout with a protruding tongue was also observed (figure 2A). This was due to reduced growth of the mandible and upper-jaw bones (figure 2E). Incomplete closure of the hard palate due to defective cartilage growth was found in all transgenic mice (figure 2C and D). Severe shortening (about 50%) of limbs was present, due to reduced growth and mineralization of long bones (figure 2F).
Membranous and periosteal bone formations, that do not require the formation of an intermediate cartilage template, were unaffected. These distinctive anomalies made it easy distinguish transgenic from normal embryos since day 16.5 p.c., however the presence of transgene was always confirmed by a diagnostic 1,168 bp long NcoI fragment in tail genomic DNA Southern blot (figure 1B).
During embryo development, the first recognizable alteration of the normal pattern of ossification was observed at 15.5 dpc At this stage, embryo size was comparable, but vertebral bodies of transgenic embryos were not stained by the bone specific dye Alizarin Red, while normal vertebrae were stained. Transgenic ribs and long bones were also faintly colored, and shorter than normal. By 16.5 dpc, transgenic embryos displayed a marked difference in skeletal growth (figure 2A). They were smaller due 
Structural and ultrastructural changes in long bones
Structural abnormalities of growth plate cartilage were found in all examined transgenic mice.
They consisted of an irregular organization of the proliferating chondrocytes that were unable to form distinct columns of cells along the bone longitudinal axis ( figure 3E ). This resulted in a short and disorganized proliferative zone, and, due to the collapse of the columns, in an increased cell number in the pre-hypertrophic region ( figure 3E ). In the proliferative zone, chondrocytes did not form clusters of dividing cells (figure 3F), and appeared larger and isolated in a matrix that was poorly stained with cationic dyes ( figure 3F ). PAS-positive cytoplasm inclusions, a hallmark of human Spodiloepiphyseal Dysplasia (SED), were never found in chondrocytes. In contrast, multiple rounded cytoplasmatic vacuoles were obvious in semithin sections ( figure 3F ).
Striking changes in the structure of the ECM of epiphyseal cartilage were observed by electron microscopy (EM) in transgenic mice. The typical dense network of thin and straight type II collagen fibrils observed in wild-type littermates ( figure 4A ) was replaced, in transgenic mice by an extremely loose, "empty looking" matrix, in which abnormally short and curved fibrils were detected (figure 4B).
Like normal fibrils observed in the epiphyseal cartilage of wild-type littermates, these fibrils were associated with proteoglycan "granules". An apparent relative excess of such granules could be observed in some areas of the matrix due to reduced number of fibrils. A marked excess of proteoglycans was noted in close association with the chondrocyte plasma membrane, resulting in obvious masses of basophilic material readily distinguishable by light microscopy in semithin section Thick, banded fibrils were never observed.
Chondrocytes embedded in this abnormal ECM were characterized by obvious dilation of the rough endoplasmatic reticulum (RER) cisternae ( figure 4D ). The dominant pattern of cisternal dilation observed in most chondrocytes consisted of multiple, small and rounded cisternal profiles. Occasionally, non-rounded, more uneven and still multiple dilations were detected. Single, large distensions were never observed.
Growth plate morphometry, proliferation and apoptosis assays
Morphometric analysis of the proximal growth plate of the second metatarsal bone revealed significant differences in the thickness of resting, proliferative, pre-hypertrophic and hypertrophic cartilages between transgenic and wild type mice ( figure 5A, B) . While, reserve, proliferating and hypertrophic cartilages were thicker in wild type, pre-hypertrophic cartilage was broader in transgenic mice.
Consistent with the depletion of type II collagen fibrils in the cartilagineous matrix, density of chondrocytes and the amount of cartilage matrix for chondrocyte were, respectively, greater and lower in transgenic compared to wild type mice ( figure 5C, D) . Thus, to investigate the potential effect of collagen II fibrils reduction on chondrocyte cell cycle, proliferation and apoptosis were assessed by BrdU labeling and TUNEL assay, respectively. No significant difference was detected for both labeling indexes comparing transgenic mice to their wild-type littermates; however, mean values for proliferation and apoptosis were lower and greater respectively in transgenic mice (figure 5E, F). These data, suggest that in transgenic Del48 mice, shortness of endochondrally formed skeletal segments is not related to an abnormal rate of chondrocyte proliferation and apoptosis.
Chondrocyte differentiation is altered in Del48 transgenic mice
Since chondrocyte proliferation and apoptosis were minimally affected by transgene expression and ECM depletion of collagen fibrils, we have determined whether this defect could affect chondrocyte maturation in growth plate cartilage. Differentiation in transgenic mice cartilages was studied following the protein and mRNA expression pattern of molecules specific of different stages of chondrocyte maturation. The expression of Col2a1, Fgfr3, Ihh and Cdkn1a was studied using highly specific antibodies. Runx2 expression was studied by in situ hybridization using specific probes. Expression of Col10a1, a collagen specifically produced and secreted in the ECM by hypertrophic chondrocytes, was studied by both immunolocalization and in situ hybridization.
Consistent with the EM finding, we observed in all cartilages of transgenic mice a substantial reduction of the amount of collagen II protein (figure 6B) that was undetectable. Normal control mice had very high level of collagen II expression throughout epiphyseal cartilage. ( figure 6A ).
Then, to recognize modifications of chondrocyte maturation, we studied the expression of the cdk inhibitor Cdkn1a, Ihh and Fgfr3. The expression of these molecules was detected in normal prehypertrophic chondrocytes (figure 6C, 6I and 6K) (24, 26, 12) , but it was almost undetectable in transgenic chondrocytes (figure 6D, 6J and 6L).
Furthermore, in the presumptive hypertrophic zone of transgenic mice, expression of collagen X was not recognizable by specific antibody (figure 6E and F). To assess whether the abnormality was due to a defective protein assembly or degradation in the pathological ECM lacking collagen II fibrils, we also determined whether Col10a1 mRNA was present. Northern blot (data not shown) and in situ hybridization did not show detectable levels of Col10a1 mRNA in cartilage of transgenic mice ( figure   6H ), while normal chondrocytes showed a highly restricted and intense signal in the hypertrophic zone ( figure 6G ).
In situ hybridization using a specific probe for Runx2, that is expressed at low level in resting and proliferating chondrocytes, but at very high levels in hypertrophic chondrocytes and in osteoblasts (14) (figure 6M), showed a very weak signal all over Del48 transgenic mice cartilage without the peak of expression that charactherizes the transition from cartilage to bone ( figure 6N ).
These experiments show that the reduction of collagen II fibrils in cartilage matrix due to transgene expression of deleted collagen II chains is associated with chondrocyte inability to undergo proper differentiation into hypertrophic cells, to express detectable levels of Col10a1, Cdkn1a, Ihh, and Fgfr3 and to sustain bone formation.
DISCUSSION
Several transgenic mice carrying dominant-negative Col2a1 mutations have been generated in the past. Such mutations were randomly distributed along the collagen triple helix and range from single amino acid (glycine) substitutions (4, 18, 19) , to large deletions (27, 22) or inactivating insertions (16).
However, nobody had previously described a deletion at the C-terminal end of the triple helix of Col2a1.
Deletions were reported in the middle (27) or at the amino terminal end of the helix (22) , and, in the case of the spontaneous mouse mutant Dominant micromelia (Dmm), in the C-propeptide (23 We generated transgenic mice carrying a transgene with the deletion of exon 48 in Col2a1. This mutation was the first identified in man (15) , and determines a non-perinatal or -neonatal lethal SED congenita phenotype, in which abnormalities in iuxtatruncal epiphysis and spine predominate. In contrast, an invariably lethal short-limbed dwarfism that better overlaps the spectrum of Hypochondrogenesis/Achondrogenesis, was observed in Del48 transgenic mice. Compared to the severity of the disease observed in the human family in which exon 48 deletion of COL2A1 was found (15) , the severity of the skeletal phenotype in our murine model appears much more pronounced. This difference can be related to the different level of expression of the transgene. In fact, in Del48 transgenic mice the amount of transgene mRNA was estimated higher than the amount of normal collagen II mRNA expressed by both wt alleles. Even though the protein biochemical consequences of the deletion remain to be characterized, it has been clearly established that the level of transgene expression is critical for the severity of phenotype (22); thus, we can assume that in the human family the expression level of procollagen chains from the mutant allele was lower than in Del48 transgenic mice.
It is reasonable that high transgene expression level can explain not only the phenotypic difference with the patients, but also the similarity with the phenotype Col2a1 null mice. Indeed, the skeletal defects of Del48 mice overlap with the most severe phenotype observed in homozygous null mice (16, 1) that also resembles human achondrogenesis type II, since mice die at birth with cleft palate, and gross morphological and histological malformations in their endoskeleton, being their long bones shortened, with a thickened cortical collar and absent endochondral bone and epiphyseal growth plates.
However, this apparent similarity reflects different pathogenetic mechanisms leading to severe reduction of collagen fibrils in cartilage matrix. While in null mice the production Col2a1 mRNA is impaired due to the insertional mutation in the genomic locus; in Del48 mice both wt alleles and the transgene are 14 fully transcribed and translated in collagen II chains that cannot assembly in functional triple helical collagen molecules due to the lack of registry generated by the 36 amino acids deletion at the C-terminal end. Because the collagen triple helix is formed by a series of hydrogen bonds that link the Gly-Xaa-Yaa sequences in one procollagen chain to equivalent Gly-Xaa-Yaa sequences in the two other chains, the presence of a shortened chain in a procollagen molecule can prevent folding into a stable triple helix and degradation of all three chains can occur in a process referred to as "procollagen suicide". Such event occurs in many other fibrillar collagens that are implicated in a variety of human pathologies and without doubts reflects the molecular events leading to ECM defect of collagen fibrils also in Del48 patients and transgenic model. 
